Workflow
磷化工
icon
Search documents
澄星股份: 江苏澄星磷化工股份有限公司监事会关于公司2025年限制性股票激励计划首次授予激励对象的核查意见(授予日)
Zheng Quan Zhi Xing· 2025-08-15 13:20
江苏澄星磷化工股份有限公司 办法》")等法律、法规及《江苏澄星磷化工股份有限公司章程》 (以下简称"《公 司章程》")的规定,江苏澄星磷化工股份有限公司(以下简称"公司")监事会 对公司 2025 年限制性股票激励计划(以下简称"本次激励计划")首次授予激励 对象认真核实后,发表如下意见: 部限制性股票外,本次获授限制性股票的其他首次授予激励对象与公司 2025 年 第三次临时股东大会审议通过的公司《2025 年限制性股票激励计划(草案)》 (以 监事会关于公司 2025 年限制性股票激励计划 首次授予激励对象的核查意见(授予日) 根据《公司法》 《证券法》 《上市公司股权激励管理办法》 (以下简称"《管理 (3)最近 12 个月内因重大违法违规行为被中国证监会及其派出机构行政处 罚或者采取市场禁入措施; (4)具有《公司法》规定的不得担任公司董事、高级管理人员的情形的; (5)法律法规规定不得参与上市公司股权激励的; 下简称"《激励计划》")中确定的激励对象条件相符; 象的情形: (1)最近 12 个月内被证券交易所认定为不适当人选; (2)最近 12 个月内被中国证监会及其派出机构认定为不适当人选; (6 ...
澄星股份: 江苏澄星磷化工股份有限公司关于调整公司2025年限制性股票激励计划相关事项的公告
Zheng Quan Zhi Xing· 2025-08-15 13:20
证券代码:600078 证券简称:澄星股份 公告编号:临 2025-053 江苏澄星磷化工股份有限公司 关于调整公司 2025 年限制性股票激励计划相关事项的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 江苏澄星磷化工股份有限公司(以下简称"公司")于 2025 年 8 月 15 日召 开第十一届董事会第二十二次会议,审议通过了《关于调整公司 2025 年限制性 股票激励计划相关事项的议案》,现将有关事项说明如下: 一、2025 年限制性股票激励计划已履行的决策程序和信息披露情况 过了《关于 <公司 ensp="ensp" 及其摘要="及其摘要" 年限制性股票激励计划="年限制性股票激励计划" 草案="草案"> 的议案》、《关 于 <公司 ensp="ensp" 年限制性股票激励计划实施考核管理办法="年限制性股票激励计划实施考核管理 办法"> 的议案》以及《关于提 请股东大会授权董事会办理公司 2025 年限制性股票激励计划相关事宜的议案》 等议案。 同日,公司召开第十一届监事会第十七次会议,审议通过了《关于 <公司 ...
澄星股份: 江苏澄星磷化工股份有限公司2025年限制性股票激励计划首次授予激励对象名单(授予日)
Zheng Quan Zhi Xing· 2025-08-15 13:20
| 江苏澄星磷化工股份有限公司 | | | | | | | --- | --- | --- | --- | --- | --- | | 一、激励对象名单及授出权益分配情况表 | | | | | | | 获授的限制性 | | | 占本激励计划授 | | 占首次授予时 | | 序 | | | | | | | 姓名 职务 | | 股票数量 | 予限制性股票总 | | 公司股本总额 | | 号 | | | | | | | (万股) | | | 数的比例 | | 的比例 | | 核心管理、业务骨干及优秀高潜员工(75 | | 人) | 1,104.00 | | 60.52% 1.67% | | 预留部分 | | 400.00 | 21.93% | 0.60% | | | 1,824.00 | 合计 | | 100% | 2.75% | | 注:1、上述任何一名激励对象通过全部有效的股权激励计划获授的本公司股票均未超过本 激励计划草案公告时公司股本总额的 1.00%。公司全部有效的激励计划所涉及的标的股票总数累 计不超过本激励计划草案公告时公司股本总额的 10.00%。 序号 姓名 职务 江苏澄星磷化工股份有限公司 监事 ...
“反内卷”下,化工品的投资机会
2025-08-14 14:48
Summary of Key Points from the Conference Call Industry Overview - The chemical industry stock index has significantly outperformed the Shanghai Composite Index year-to-date, with notable performances in the plastics and rubber sub-sectors, achieving increases of 48% and 35% respectively, driven by small-cap effects and the popularity of industries such as robotics and AI materials [1][3][4]. Core Insights and Arguments - The divergence between chemical stock performance and commodity futures is evident, with stock prices influenced by both EPS and valuation changes, with valuation changes being more pronounced [1][6]. - The delay in US-China tariffs and anti-involution measures have positively impacted stock valuation recovery [1][6]. - Anti-involution policies have effectively balanced supply and demand by eliminating outdated production capacity and promoting industry self-discipline, leading to an increase in chemical product prices [1][9]. - The chemical sector faces challenges of overcapacity and prices below cost due to disorderly competition, which the industry typically addresses through self-discipline, extended maintenance periods, and the elimination of outdated capacity [1][11]. Sub-Sector Performance - Four sub-sectors expected to see improved performance in the second half of the year include fluorochemicals and refrigerants, phosphorus chemicals, pesticides, and sugar substitutes, benefiting from quota policies, strong downstream demand, cyclical rebounds, and enhanced export competitiveness [1][13][14]. - Mid-year reports indicate strong performance in refrigerants and phosphorus chemicals, with expectations for continued relative gains throughout the year [1][14][15]. Recommended Investment Opportunities - Key recommendations for the second half of the year include sectors such as smart devices, phosphorus chemicals, pesticides, and sugar substitutes, with specific companies highlighted: - **Juhua Co.** (Refrigerants) - Projected profit of 2 billion yuan in 2025, a year-on-year increase of approximately 150% [2][17]. - **Yuntianhua Co.** (Phosphorus Chemicals) - Last year's profit of 2.7 billion yuan, with 1.3 billion yuan achieved in Q1 2025 [2][17]. - **Yangnong Chemical** (Pesticides) - Expected slight growth in 2025 [2][17]. - **Bailong Chuangyuan** (Sugar Substitutes) - Q1 2025 profit of 80 million yuan, a year-on-year increase of over 50% [2][17]. Market Dynamics and Price Trends - The recent 10% increase in commodity prices is attributed to supply-demand imbalances exacerbated by anti-involution policies, which have led to coordinated maintenance schedules among manufacturers [1][8][9]. - The chemical industry is implementing measures to achieve supply-demand balance and enhance product prices through the elimination of outdated capacity and self-regulation [1][9][10]. Additional Insights - The chemical sector is currently in a cyclical bottoming phase, with expectations for gradual improvement starting in 2025 due to policy changes and improved liquidity [1][13]. - The performance of the recommended sectors is expected to continue contributing positively to earnings, with the logic of growth still unfolding [2][16]. Elasticity of Recommended Stocks - The stocks are ranked by elasticity from highest to lowest: Bailong Chuangyuan > Yangnong Chemical > Juhua Co. > Yuntianhua Co., reflecting higher growth potential in smaller market cap companies [2][18].
宜宾天原集团股份有限公司 关于控股股东之一致行动人国有股权无偿划转的进展公告
Group 1 - The company announced the progress of the free transfer of state-owned equity involving its controlling shareholder's action partner, Sichuan Yuanling Industrial Investment Group Co., Ltd. [2] - A total of 14,326,647 shares, representing 1.1% of the company's equity, will be transferred from Yuanling Investment to its parent company, Sichuan Gangrong Investment Development Group Co., Ltd. [3] - The transfer does not change the controlling shareholder or the actual controller of the company, nor does it affect the shareholding ratio of the controlling shareholder and its action partners [4] Group 2 - The company’s subsidiary, Mabi Wuqiong Mining Co., Ltd., has completed the safety facility acceptance for the 900,000 tons/year Dingjia Phosphate Mine (Phase II) mining project [7] - The phosphate project is currently in trial production and is expected to enhance the company's future operating performance and overall strength, positively impacting long-term development [7]
云天化:8月11日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-08-11 11:45
Group 1 - The company Yuntianhua (SH 600096) held its first board meeting of the tenth session on August 11, 2025, to discuss the election of the chairman of the audit committee [1] - For the year 2024, Yuntianhua's revenue composition is as follows: fertilizers account for 43.87%, trade for 41.57%, phosphate chemicals for 4.5%, others for 3.98%, and engineering materials for 2.36% [1] - As of the report date, Yuntianhua's market capitalization is 45.4 billion yuan [1]
澄星股份: 江苏澄星磷化工股份有限公司董事会薪酬与考核委员会关于公司2025年限制性股票激励计划首次授予激励对象名单的公示情况说明及核查意见
Zheng Quan Zhi Xing· 2025-08-08 16:23
公司已在上海证券交易所网站(www.sse.com.cn)上公告了《江苏澄星磷化工 股份有限公司2025 年限制性股票激励计划(草案)》及其摘要、《江苏澄星磷 化工股份有限公司 2025 年限制性股票激励计划实施考核管理办法》以及《江苏 澄星磷化工股份有限公司2025 年限制性股票激励计划首次授予激励对象名单》。 公司于2025年7月30日至2025年8月8日对本次激励计划拟首次授予激励对象 的姓名和职务进行了内部公示,公示期共计 10 日。在公示期限内,公司员工可 通过来电、来访的方式向董事会薪酬与考核委员会进行反馈,公司董事会薪酬 与考核委员会对相关反馈进行记录。 在公示期间内,未有任何组织或个人对本次激励计划拟首次授予激励对象 提出异议。 证券代码:600078 证券简称:澄星股份 公告编号:临2025-046 江苏澄星磷化工股份有限公司董事会薪酬与考核委员会 关于公司 2025 年限制性股票激励计划首次授予激励对象名单 的公示情况说明及核查意见 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 根据《上市公司股权激励管理 ...
澄星股份: 江苏澄星磷化工股份有限公司监事会关于公司2025年限制性股票激励计划首次授予激励对象名单的公示情况说明及核查意见
Zheng Quan Zhi Xing· 2025-08-08 16:23
公司已在上海证券交易所网站(www.sse.com.cn)上公告了《江苏澄星磷化工 股份有限公司 2025 年限制性股票激励计划(草案)》及其摘要、《江苏澄星磷 化工股份有限公司 2025 年限制性股票激励计划实施考核管理办法》以及《江苏 澄星磷化工股份有限公司 2025 年限制性股票激励计划首次授予激励对象名单》。 公司于2025年7月30日至2025年8月8日对本次激励计划拟首次授予激励对象 的姓名和职务进行了内部公示,公示期共计 10 日。在公示期限内,公司员工可 通过来电、来访的方式向监事会进行反馈,公司监事会对相关反馈进行记录。 证券代码:600078 证券简称:澄星股份 公告编号:临2025-047 江苏澄星磷化工股份有限公司监事会 关于公司 2025 年限制性股票激励计划首次授予激励对象 名单的公示情况说明及核查意见 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 根据《上市公司股权激励管理办法》(以下简称"《管理办法》")的有关 规定,江苏澄星磷化工股份有限公司(以下简称"公司")于2025年7月29日召开 第 ...
川恒股份股价微跌0.28% 中报预增47%至66%引关注
Jin Rong Jie· 2025-08-05 17:03
Group 1 - The stock price of Chuanheng Co., Ltd. is reported at 24.78 yuan, down 0.28% from the previous trading day, with a trading volume of 114 million yuan and a fluctuation of 1.01% [1] - Chuanheng Co., Ltd. specializes in the research, production, and sales of phosphate chemical products, which are widely used in agriculture, industry, and new energy materials [1] - The company expects a net profit attributable to shareholders of 520 million to 590 million yuan for the first half of 2025, representing a year-on-year growth of 47.03% to 66.82% [1] Group 2 - As of July 31, 2025, the number of shareholders of the company is 26,700, an increase of 1.74% compared to the previous period [1] - On August 5, 2025, the net outflow of main funds was 5.62 million yuan, with a cumulative net outflow of 8.81 million yuan over the past five days [1]
帮主郑重:8月5日龙虎榜惊现机构抢筹!三板块暗藏黄金,外资悄然锁仓
Sou Hu Cai Jing· 2025-08-05 16:38
Group 1: Communication Equipment - Dongxin Peace has a net buying amount of 207 million, indicating significant institutional interest with a turnover rate of 20.87% and a transaction volume of 1.8 billion [3] - The breakthrough in large-scale array technology by ZTE Corporation has secured its position in the 6G standard, contributing to a 1.75% increase in the communication equipment index [3] - Dongxin Peace, as a leader in smart cards, is deeply integrated with operators' 5G-A construction, with expectations of at least doubling its performance upon the commercial rollout of 6G [3] Group 2: Medical Services - Innovation Medical has a net buying amount of 200 million, with a 10% increase and a 25% turnover rate, indicating a robust exchange of shares [3] - The approval of the second-class certification for the Bolein brain-machine upper limb exoskeleton rehabilitation device is set to tap into the billion-dollar home rehabilitation market [3] - With over 380 million people aged 60 and above in China, the demand for rehabilitation services is expected to grow by 15% annually, positioning the company for long-term benefits despite a previous loss of 34.29 million [3] Group 3: Automation Equipment - Aerospace Science and Technology has seen foreign capital increase by 52.74 million, driven by two main factors: a recovery in orders and foreign exchange gains [3] - The company is projected to turn a profit of 12.27 million in 2024 after a loss of 14.6 million in 2023, indicating a clear turnaround strategy [3] - The push for smart vehicles by policy support is expected to enhance the company's valuation recovery [5] Group 4: Foreign Capital Adjustment - Zhongyida has attracted 49.68 million from the Shanghai Stock Connect, focusing on phosphate chemical production for new energy battery materials, showcasing a strong technical barrier [4] - Aerospace Science and Technology's foreign capital increase reflects a strategic focus on leading technologies in the automotive sector, with 76% of its revenue coming from overseas [4] - The national equipment update fund of 10 billion is now in place, with over 30% penetration in intelligent transformation [4]